New Approaches in the Management of Inhibitor Patients
Author:
Publisher
S. Karger AG
Subject
Hematology,General Medicine
Reference36 articles.
1. The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977-99
2. Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group
3. Inhibitors: resolving diagnostic and therapeutic dilemmas
4. Reduction of the antigenicity of factor VIII toward complex inhibitory antibody plasmas using multiply-substituted hybrid human/porcine factor VIII molecules
5. Age at first treatment and immune tolerance to factor VIII in severe hemophilia
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Emerging drugs for hemophilia A: insights into phase II and III clinical trials;Expert Opinion on Emerging Drugs;2021-10-02
2. A non-viral genome editing platform for site-specific insertion of large transgenes;Stem Cell Research & Therapy;2020-09-03
3. Advancement in the treatment of haemophilia;International Journal of Biological Macromolecules;2018-10
4. Is some better than none: are TEG and TGA profiles different in severe FVIII-deficient patients with inhibitors?;Haemophilia;2014-12-11
5. Hemophilic Arthropathy;Kelley's Textbook of Rheumatology;2013
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3